Cuban Deputy Prime Minister Calls for Collaboration in Biomanufacturing: Strengthening Science Collaboration
As a prominent figures from India and Cuba gather at the 65th anniversary of their diplomatic relations, it is clear that collaboration in science and technology is taking an unprecedented turn. The conversation centers on biotechnology—specifically biomanufacturing and strengthening of science partnerships. Dr. H.E. Eduardo Martínez Díaz, the Cuban Deputy Prime Minister, has emphasized the importance of these areas for the global economy and innovation.
The Meeting Explores Key Areas
Dr. Jitendra Singh, the Union Minister for Science, Technology, Earth Sciences, and Environment, joined the meeting to discuss ways to deepen collaboration in medical research, vaccine development, and biomanufacturing. The discussions revealed that these fields are crucial for a science-driven society to have a global influence at scale.
India’s progress in biotechnology has been remarkable, with its G20 Initiative on Bioeconomy (GIB) achieving a significant milestone—4.25% contribution to GDP from 2014 to 2023, two years ahead of the 2025 target. India is also making strides in biomanufacturing through initiatives like DBT’s efforts in GIB and the BioE3 Policy, which aims to revolutionize bio-based products.
Cuba, meanwhile, has demonstrated success in biotechnology, particularly in developing low-cost vaccines and pioneering cancer treatments. Its commitment to innovation aligns with the growing interest of both nations in Ayurveda (medicatory practices rooted in natural medicine) and Indian naturopathy for global expansion.
The Collaboration: Benefits and Challenges
Both countries have discussed strengthening existing agreements in health, medicine, and biotechnology. Cuba’s focus on biomanufacturing is a sign of its growing interest in global collaboration. India, on the other hand, is actively seeking opportunities to strengthen these partnerships, driven by both its scientific and economic goals.
The Department of Biotechnology (DBT) plays a pivotal role in this effort, with initiatives like “Mission COVID Suraksha” under Atma Nirbhar Bharat 3.0, showcasing DBT’s commitment to vaccine development and manufacturing. Additionally, BIOTECH Industry Research Assistance Council (BIRAC) continues to foster innovation and entrepreneurship in India’s biotech ecosystem.
Cuba has already extended an invitation to Dr. Jitendra Singh to visit Havana and lead a delegation to Bio-Habana 2026—a global conference on biotechnology. This move reflects both nations’ optimism about expanding engagement in this sector.
Conclusion: A Step Toward Global Collaboration
This meeting is not just about biotechnology—it’s about the future of global science. It highlights how collaboration can drive innovation, foster partnerships, and contribute to both countries’ global goals. As Cuba continues to grow its interest in Ayurveda, India has every reason to take this forward, knowing that together, they can strengthen their science diplomacy and make a significant impact on the world stage.
In summary, the conversation underscores the importance of biomanufacturing and vaccine development in shaping a more globalized and collaborative future. Both Cuba and India are well positioned to contribute significantly to this vision.